Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays

Apetrei, 1996, Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions, AIDS, 14, 57, 10.1097/00002030-199612000-00002 Barin, 1996, Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping, AIDS Res. Hum. Retroviruses, 13, 1279, 10.1089/aid.1996.12.1279 Brennan, 1997, Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda, AIDS, 11, 1823, 10.1097/00002030-199715000-00006 Brust, 2000, Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test, J. Virol. Methods, 90, 153, 10.1016/S0166-0934(00)00229-9 Busch, 1990, Screening of selected male blood donors for p24 antigen human immunodeficiency virus type 1, N. Engl. J. Med., 8, 1308, 10.1056/NEJM199011083231904 Couroucé, 1988, Blood transfusion and human immunodeficiency virus (HIV) antigen, Ann. Intern. Med., 108, 771, 10.7326/0003-4819-108-5-771_2 Couroucé, 1999, Tests de depistage combiné des anticorps anti-VIH et de l’Age p24, Gazette Transfus, 155, 4 Couturier, 2000, HIV-1 diversity in France, 1996–1998. The AC 11 laboratory network, AIDS, 3, 289, 10.1097/00002030-200002180-00011 Dodd, 2002, Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population, Transfusion, 42, 975, 10.1046/j.1537-2995.2002.00174.x Gürtler, 1998, Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay, J. Virol. Methods, 75, 27, 10.1016/S0166-0934(98)00094-9 Jagodzinski, 2000, Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests, J. Clin. Microbiol., 38, 1247, 10.1128/JCM.38.3.1247-1249.2000 Laperche, 2000, Les tests de dépistage combiné de l’antigène p24 et des anticorps anti-VIH dans l’infection précoce à VIH-1, Transfus. Clin. Biol., 7, 18, 10.1016/S1246-7820(00)80011-7 Ly, 2000, Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing, J. Clin. Microbiol., 38, 2459, 10.1128/JCM.38.6.2459-2461.2000 Ly, 2001, Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays, Eur. J. Clin. Microbiol. Infect. Dis., 20, 104, 10.1007/s100960000430 Ly, 2001, Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV serconversion sensitivity and subtype detection, J. Clin. Microbiol., 39, 3122, 10.1128/JCM.39.9.3122-3128.2001 Tersmette, 1989, Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24 gag, Virology, 171, 149, 10.1016/0042-6822(89)90521-7 Van Binsbergen, 1998, Strongly enhanced sensitivity of a direct anti-HIV-1/2 assay in seroconversion by incorporation of HIV p24 Ag detection: a new generation Vironostika HIV Uniform II, J. Virol. Methods, 76, 59, 10.1016/S0166-0934(98)00126-8 Weber, 1998, Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assay, J. Clin. Microbiol., 36, 2235, 10.1128/JCM.36.8.2235-2239.1998 Weber, 2002, Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, Vidas HIV Duo Ultra, J. Clin. Microbiol., 40, 1420, 10.1128/JCM.40.4.1420-1426.2002